{@shortdesc}

{@title}
{@headline}
Slide: {@currentrow} of {ds_RowCount}  PreviousStopPlayNext

The Drug Safety Executive Council (DSEC) is a peer-to-peer membership of 2,000 drug safety leaders with the common objective of advancing the development of better and safer medicines.  Learn More.

DSEC also manages a Technology Evaluation Consortium, made up of biopharmaceutical companies, that qualifies novel, preclinical safety platforms. Learn more at www.drugsafetycouncil.org.

Why Join DSEC?

Regular membership is complimentary
Engage in member-driven discussions, research, and presentations that will help you lead your organization to better decision making
Network with other high-level executives at leading biopharmaceutical companies to drive change that will encourage business growth
Membership is limited to leaders representing companies who develop small and large molecule pharmaceuticals

 
 
Featured Events & Content

On Demand: Advanced Cardiac Safety: De-Risking Drug Candidates in Early Clinical Development
Download the recording and slides for this webinar which took place on July 15, 2010 at 11:00 a.m. EDT.
OnDemand: Improved Strategies for Pre-Clinical Cardiac Testing
Download the recording and slides for this webinar which took place on June 23, 2010 at 11:00 a.m. EDT.
Biocortech and DSEC Announce Technology Evaluation Consortium to Validate Toxicogenomic Assay
View the press release for details.
DSEC is a sponsor of the Post-Approval Drug Safety Strategy Series
DSEC members receive a discount to attend on November 8-9, 2010 in Philadelphia, PA.
DSEC is a sponsor of Mitigating Safety Risks in Early Clinical Development
DSEC members receive a discount to attend on November 8-9, 2010 in Philadelphia, PA.

On-Demand Web Sessions

Webinar: Next Big Thing in Discovery Toxicology
Download the recording and slides for this webinar which took place May 20, 2010 at 11:00 a.m. EDT.
Webinar: Predictive Safety Biomarkers in Non-Clinical Development
Download the recording and slides for this webinar which took place on April 15, 2010 at 11:00 a.m. EDT.
Webinar: Avoiding False Cardiac Signals in Early Drug Development
Download the recording and slides for this webinar which took place on January 28, 2010 at 11:00 a.m. EST.
Virtual Conference: Pre-GLP Safety Strategy Session
Download the recording and slides from the Virtual Conference held on Thursday, Jan 7, 2010.

Executive Summaries: Benchmarking Studies/Reports

Executive Summary: Confronting Major Safety Issues of the 21st Century
Executive Summary from the Inaugural DSEC Member Summit
The Emergence of High-Content Screening as a Tool for Safety Assessment
Drug safety challenges rank as the leading cause of attrition of compounds in clinical development